This site is intended for healthcare professionals
News

Complete Response Letter for obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis (NASH).- Intercept Pharmaceuticals

Read time: 1 mins
Last updated:30th Jun 2020
Published:30th Jun 2020
Condition: Non Alcoholic Steatohepatitis (NASH)
Type: drug
Register free for full access to medthority.com